Gold prices have hovered below the $1,900 mark since November 9, as progress towards an effective coronavirus brightened the global economic outlook. Moderna became the second US company in a week to report positive results from its COVID-19 vaccine trial, pushing investors into riskier assets. Still, prospects of further economic aid in the light of rising coronavirus cases continue to boost the metal’s appeal as an inflation hedge.